Private Equity
The New York firm, which invests in healthcare services companies in the lower-middle-market, beat its $125 million target.
2 min read · 31 July 2019
Arsenal Capital Partners has acquired Caprion Biosciences from GHO Capital Partners LLP. Financial terms weren’t announced. Caprion is a specialized laboratory service business serving pharma and biotech companies.
3 min read · 31 July 2019
Welsh, Carson, Anderson & Stowe and Walgreens are investing in Shields Health Solutions. Financial terms weren’t announced. Shields is a specialty pharmacy integrator and care provider.
4 min read · 31 July 2019
Advancing Eyecare has acquired Ophthalmic Instruments & Consulting Company, a provider of classical and diagnostic equipment in the Pacific Northwest. No financial terms were disclosed. Advancing Eyecare is backed by Atlantic Street Capital.
2 min read · 31 July 2019
Caprion Biosciences, a portfolio company of Arsenal Capital Partners, is combining with HistoGeneX. Financial terms weren’t announced. HistoGeneX is backed by Waterland Private Equity Investments. HistoGeneX provides pathology and biomarker assessment services for drug development.
5 min read · 31 July 2019
The EQT Infrastructure II fund agreed to sell Charleston Holding to KOS and Primonial REIM. Financial terms weren’t announced. Charleston, of Füssen, Germany, operates 47 care homes with 4,050 beds, four daycare centers and seven ambulatory care locations.
3 min read · 31 July 2019
During CD&R’s investment period, Ebitda and revenue grew 60 percent and 40 percent, respectively.
2 min read · 31 July 2019
New Frontier Corporation has agreed to acquire United Family Healthcare, a private healthcare operator in China, for an enterprise value of $1.44 million. The sellers include TPG and Fosun Pharma. NFC's backers include Vivo Capital and Nan Fung Group.
10 min read · 30 July 2019
UK-based PredictImmune, a developer of prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, has closed its Series B funding round at 10 million pounds. The investors included Parkwalk, Cambridge Enterprise and BGF.
1 min read · 30 July 2019
Arcline Investment Management has made an investment in Dark Horse Consulting Group, a global consultancy practice specializing in cell and gene therapy product development. No financial terms were disclosed.
2 min read · 30 July 2019
